Helvetic BioPharma ^None

Helvetic BioPharma is a Swiss-based bio-pharmaceutical company that focuses on research, development, production, and marketing of pharmaceutical products in the fields of Oncology and Urology. They use recombinant proteins biopharmaceutical and synthetic peptides as their technology platforms. The company has a customer-focused approach to developing, producing, and marketing high-quality affordable medicines. They have worldwide commercial presence and rely on partners for the promotion of their portfolio. Their product portfolio mainly consists of recombinant proteins, hormones, and peptides. They also offer PEGylation, which is a chemical modification of therapeutic proteins to create long-acting molecules.